Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jaap Seelig"'
Autor:
Luc J.H.J. Theunissen, Jeroen A.A. van de Pol, Gijs J. van Steenbergen, Henricus-Paul Cremers, Dennis van Veghel, Pepijn H. van der Voort, Peter E. Polak, Sylvie F.A.M.S. de Jong, Jaap Seelig, Geert Smits, Hareld M.C. Kemps, Lukas R.C. Dekker
Publikováno v:
Health and Quality of Life Outcomes, Vol 21, Iss 1, Pp 1-10 (2023)
Abstract Background In this study, the prognostic value of AF-related quality of life (AFEQT) at baseline on Major Adverse Cardiovascular Events (MACE) and improvement of perceived symptoms (EHRA) was assessed. Furthermore, the relationship between Q
Externí odkaz:
https://doaj.org/article/3f12ef2637bf4f86bc6317ad6ba669a4
Autor:
Marco Alings, Frans H Rutten, Bart van den Bemt, Ewoud J Van Dijk, Suzanne C Cannegieter, Menno V Huisman, Michiel Rienstra, Frederikus A Klok, Geert-Jan Geersing, Marc A Brouwer, Robert G Tieleman, Gordon Chu, Jaap Seelig, Emmy M Trinks-Roerdink, Anouk P van Alem, Lucas VA Boersma, Hugo ten Cate, Charles JHJ Kirchhof, Harry JGM Crijns, Isabelle C van Gelder, Joris R de Groot, Frank R den Hartog, Jonas SSG de Jong, Sylvie de Jong, Timo Lenderink, Justin G Luermans, Joan G Meeder, Ron Pisters, Peter Polak, Frans Smeets, Giovanni JM Tahapary, Luc Theunissen, Serge A Trines, Pepijn van der Voort, Martin EW Hemels
Publikováno v:
BMJ Open, Vol 10, Iss 8 (2020)
Introduction Anticoagulation therapy is pivotal in the management of stroke prevention in atrial fibrillation (AF). Prospective registries, containing longitudinal data are lacking with detailed information on anticoagulant therapy, treatment adheren
Externí odkaz:
https://doaj.org/article/36dfb623da8849bd801197b90789f8e0
Autor:
Jaap Seelig, Martin E W Hemels
Publikováno v:
Europace, 25, 249-250
Europace, 25, 2, pp. 249-250
Europace, 25, 2, pp. 249-250
Contains fulltext : 290769.pdf (Publisher’s version ) (Open Access)
Autor:
Jaap Seelig, Gordon Chu, Emmy M. Trinks-Roerdink, Ron Pisters, Tim A.C. de Vries, Hugo ten Cate, Geert-Jan Geersing, Frans H. Rutten, Menno V. Huisman, Martin E.W. Hemels
Publikováno v:
Heart rhythm, 19(5), 860-861. Elsevier
Heart Rhythm, 19, 5, pp. 860-861
Heart Rhythm, 19, 860-861
Heart Rhythm, 19(5), 860-861. Elsevier Science
Heart Rhythm, 19, 5, pp. 860-861
Heart Rhythm, 19, 860-861
Heart Rhythm, 19(5), 860-861. Elsevier Science
Item does not contain fulltext
Autor:
Pia Raanani, Nir Livneh, Jaap Seelig, Uri Rozovski, Anna Falanga, Genady Drozdinsky, Dionne C.W. Braeken, Avi Leader, Hugo ten Cate, Tamar Berger, Anat Gafter-Gvili, Galia Spectre
Publikováno v:
Journal of Thrombosis and Thrombolysis, 52(2), 590-596. Springer, Cham
Managing anticoagulation in hematological malignancy patients with atrial fibrillation and thrombocytopenia is a clinical challenge with limited data. We aimed to identify anticoagulation management strategies and evaluate bleeding and thrombosis rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cd1348f1ba1f28f7b1d41d9fac95b41
https://cris.maastrichtuniversity.nl/en/publications/9fcbabda-5b68-4523-bb4e-28e7e9fcf033
https://cris.maastrichtuniversity.nl/en/publications/9fcbabda-5b68-4523-bb4e-28e7e9fcf033
Publikováno v:
Vascular Health and Risk Management. 15:399-408
Stroke prevention with oral anticoagulants in patients with atrial fibrillation predisposes for bleeding. As a result, in select patient groups anticoagulation is withheld because of a perceived unfavorable risk-benefit ratio. Reasons for withholding
Autor:
Nir, Livneh, Dionne, Braeken, Genady, Drozdinsky, Anat, Gafter-Gvili, Jaap, Seelig, Uri, Rozovski, Tamar, Berger, Pia, Raanani, Anna, Falanga, Hugo, Ten Cate, Galia, Spectre, Avi, Leader
Publikováno v:
Journal of thrombosis and thrombolysis. 52(2)
Managing anticoagulation in hematological malignancy patients with atrial fibrillation and thrombocytopenia is a clinical challenge with limited data. We aimed to identify anticoagulation management strategies and evaluate bleeding and thrombosis rat
Autor:
Jaap Seelig, J. R. de Groot, Frans H. Rutten, Gordon Chu, Menno V. Huisman, Martin E.W. Hemels, Emmy M. Trinks-Roerdink, Geert-Jan Geersing
Publikováno v:
Netherlands Heart Journal, 28, 19-24
Netherlands Heart Journal, 28, Suppl 1, pp. 19-24
Netherlands Heart Journal
Netherlands Heart Journal, 28(SUPPL 1), 19-24. BOHN STAFLEU VAN LOGHUM BV
Netherlands Heart Journal, 28, Suppl 1, pp. 19-24
Netherlands Heart Journal
Netherlands Heart Journal, 28(SUPPL 1), 19-24. BOHN STAFLEU VAN LOGHUM BV
Contains fulltext : 225355.pdf (Publisher’s version ) (Open Access) In recent years, as more and more experience has been gained with prescribing direct oral anticoagulants (DOACs), new research initiatives have emerged in the Netherlands to improv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8606e142ec0ec06dd3d6de3e28e3ef9b
http://hdl.handle.net/2066/225355
http://hdl.handle.net/2066/225355
Autor:
Martin E.W. Hemels, Jaap Seelig
Publikováno v:
Netherlands Heart Journal
Autor:
Seelig J; Rijnstate, afd. Cardiologie, Arnhem.; Contact: Jaap Seelig (jseelig@rijnstate.nl)., Pisters R; Rijnstate, afd. Cardiologie, Arnhem., Alings AMWM; Amphia ziekenhuis, afd. Cardiologie, Breda., Hemels MEW; Rijnstate, afd. Cardiologie, Arnhem.
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2023 Feb 08; Vol. 167. Date of Electronic Publication: 2023 Feb 08.